_id
691489a4ccc777a4e85d988b
Ticker
OZYMF
Name
Orphazyme A/S
Exchange
PINK
Address
Lyskær 8A, Herlev, Denmark, 2730
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.strategic-partners.dk
Description
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Last Close
90
Volume
-
Current Price
90
Change
0
Last Updated
2026-01-06T08:48:42.192Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3721410
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1391
Operating Income
-1391
Interest Expense
-
Pretax Income
-1187
Net Income
-1187
Eps
-28.001887237556026
Dividends Per Share
-
Shares Outstanding
41349
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
204
Cash
3222000
Short Term Investments
12053000
Receivables
-
Inventories
-
Total Current Assets
15277000
Property Plant Equipment
-
Total Assets
18850000
Payables
789000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
789000
Equity
18061000
Bs_currency_symbol
DKK
Depreciation
1491
Change In Working Capital
-3487
Cash From Operations
-4628
Capital Expenditures
0
Cash From Investing
3964
Cash From Financing
-
Net Change In Cash
3222
Cf_currency_symbol
-
PE
-
PB
0.00021123415093294944
ROE
-0.006572172083494822
ROA
-0.006297082228116711
FCF
-4628
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
5.5
Net Net Investing Score
7.5
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1391
Quarters > 0 > income Statement > operating Income
-1391
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1187
Quarters > 0 > income Statement > net Income
-1187
Quarters > 0 > income Statement > eps
-28.001887237556026
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
42.39
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
204
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3222000
Quarters > 0 > balance Sheet > short Term Investments
12053000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
15277000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
18850000
Quarters > 0 > balance Sheet > payables
789000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
789000
Quarters > 0 > balance Sheet > equity
18061000
Quarters > 0 > balance Sheet > currency_symbol
DKK
Quarters > 0 > cash Flow > net Income
-1187
Quarters > 0 > cash Flow > depreciation
1491
Quarters > 0 > cash Flow > change In Working Capital
-3487
Quarters > 0 > cash Flow > cash From Operations
-4628
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
3964
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
3222
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-28.001887237556026
Quarters > 0 > ratios > PB
0.00021123415093294944
Quarters > 0 > ratios > ROE
-0.006572172083494822
Quarters > 0 > ratios > ROA
-0.006297082228116711
Quarters > 0 > ratios > FCF
-4628
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1895
Quarters > 1 > income Statement > operating Income
-1895
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2146
Quarters > 1 > income Statement > net Income
-2146
Quarters > 1 > income Statement > eps
-0.0005543500723289936
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3871200
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-251
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3886000
Quarters > 1 > balance Sheet > short Term Investments
16086000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
20008000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
23558000
Quarters > 1 > balance Sheet > payables
4310000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4310000
Quarters > 1 > balance Sheet > equity
19248000
Quarters > 1 > balance Sheet > currency_symbol
DKK
Quarters > 1 > cash Flow > net Income
-202848
Quarters > 1 > cash Flow > depreciation
2095
Quarters > 1 > cash Flow > change In Working Capital
-3419693
Quarters > 1 > cash Flow > cash From Operations
-3360711
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-12320
Quarters > 1 > cash Flow > cash From Financing
5306000
Quarters > 1 > cash Flow > net Change In Cash
-13973
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0005543500723289936
Quarters > 1 > ratios > PB
18.100997506234414
Quarters > 1 > ratios > ROE
-0.011149210307564422
Quarters > 1 > ratios > ROA
-0.009109432040071313
Quarters > 1 > ratios > FCF
-3360711
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-1694
Quarters > 2 > income Statement > operating Income
1694
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
1848
Quarters > 2 > income Statement > net Income
1848
Quarters > 2 > income Statement > eps
0.00005200067533344589
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35538000
Quarters > 2 > income Statement > income Tax Expense
-2983800
Quarters > 2 > income Statement > EBITDA
3696000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
154
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
13973000
Quarters > 2 > balance Sheet > short Term Investments
3781000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17850000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
17850000
Quarters > 2 > balance Sheet > payables
1761000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1761000
Quarters > 2 > balance Sheet > equity
16089000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
1848
Quarters > 2 > cash Flow > depreciation
-1894
Quarters > 2 > cash Flow > change In Working Capital
-2307
Quarters > 2 > cash Flow > cash From Operations
-289
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
2993
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
13973
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.00005200067533344589
Quarters > 2 > ratios > PB
198.79545030766363
Quarters > 2 > ratios > ROE
0.011486108521349991
Quarters > 2 > ratios > ROA
0.010352941176470589
Quarters > 2 > ratios > FCF
-289
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-847
Quarters > 3 > income Statement > operating Income
847
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
924
Quarters > 3 > income Statement > net Income
924000
Quarters > 3 > income Statement > eps
0.026000337666722946
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
35538000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-100
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
77
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
13973000
Quarters > 3 > balance Sheet > short Term Investments
3781000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17850000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
17850000
Quarters > 3 > balance Sheet > payables
1761000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1761000
Quarters > 3 > balance Sheet > equity
16088999
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
924
Quarters > 3 > cash Flow > depreciation
-947
Quarters > 3 > cash Flow > change In Working Capital
-1153.5
Quarters > 3 > cash Flow > cash From Operations
-144.5
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
1352
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.026000337666722946
Quarters > 3 > ratios > PB
198.79546266364986
Quarters > 3 > ratios > ROE
5.743054617630345
Quarters > 3 > ratios > ROA
5.176470588235294
Quarters > 3 > ratios > FCF
-144.5
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
59
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
201
Annuals > 0 > income Statement > operating Income
-201
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-298
Annuals > 0 > income Statement > net Income
-298
Annuals > 0 > income Statement > eps
-8.026936026936027e-8
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3712500000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-97
Annuals > 0 > income Statement > currency_symbol
DKK
Annuals > 0 > balance Sheet > cash
3886000
Annuals > 0 > balance Sheet > short Term Investments
16086000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
20008000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
23558000
Annuals > 0 > balance Sheet > payables
4310000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4310000
Annuals > 0 > balance Sheet > equity
19248000
Annuals > 0 > balance Sheet > currency_symbol
DKK
Annuals > 0 > cash Flow > net Income
-201000
Annuals > 0 > cash Flow > depreciation
201000
Annuals > 0 > cash Flow > change In Working Capital
-3422000
Annuals > 0 > cash Flow > cash From Operations
-3361000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-9327000
Annuals > 0 > cash Flow > cash From Financing
5306000
Annuals > 0 > cash Flow > net Change In Cash
-7383000
Annuals > 0 > cash Flow > currency_symbol
DKK
Annuals > 0 > ratios > PE
-8.026936026936027e-8
Annuals > 0 > ratios > PB
17358.9463840399
Annuals > 0 > ratios > ROE
-0.0015482128013300082
Annuals > 0 > ratios > ROA
-0.0012649630698701078
Annuals > 0 > ratios > FCF
-3361000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
27041
Annuals > 1 > income Statement > operating Income
-27041000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-26048000
Annuals > 1 > income Statement > net Income
-26048000
Annuals > 1 > income Statement > eps
-0.737652922519257
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
35312000
Annuals > 1 > income Statement > income Tax Expense
-782
Annuals > 1 > income Statement > EBITDA
-12102
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
993000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11269000
Annuals > 1 > balance Sheet > short Term Investments
6944000
Annuals > 1 > balance Sheet > receivables
1099000
Annuals > 1 > balance Sheet > inventories
-1099
Annuals > 1 > balance Sheet > total Current Assets
19312000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
19312000
Annuals > 1 > balance Sheet > payables
5070000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5070000
Annuals > 1 > balance Sheet > equity
14242000
Annuals > 1 > balance Sheet > currency_symbol
DKK
Annuals > 1 > cash Flow > net Income
-26048
Annuals > 1 > cash Flow > depreciation
782
Annuals > 1 > cash Flow > change In Working Capital
10651
Annuals > 1 > cash Flow > cash From Operations
-20021000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-6944000
Annuals > 1 > cash Flow > cash From Financing
-685000
Annuals > 1 > cash Flow > net Change In Cash
-27649000
Annuals > 1 > cash Flow > currency_symbol
DKK
Annuals > 1 > ratios > PE
-0.737652922519257
Annuals > 1 > ratios > PB
223.14843420867854
Annuals > 1 > ratios > ROE
-182.89566072180875
Annuals > 1 > ratios > ROA
-134.87986743993372
Annuals > 1 > ratios > FCF
-20021000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
782000
Annuals > 2 > income Statement > gross Profit
-782000
Annuals > 2 > income Statement > operating Expenses
40459000
Annuals > 2 > income Statement > operating Income
-41241000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-41056000
Annuals > 2 > income Statement > net Income
-110594000
Annuals > 2 > income Statement > eps
-3.1357282599449943
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
35269000
Annuals > 2 > income Statement > income Tax Expense
-2750000
Annuals > 2 > income Statement > EBITDA
-40459000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
185000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
38918000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2324986
Annuals > 2 > balance Sheet > inventories
2
Annuals > 2 > balance Sheet > total Current Assets
56826000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
56826000
Annuals > 2 > balance Sheet > payables
4357000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
15852000
Annuals > 2 > balance Sheet > equity
40974000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
35072
Annuals > 2 > cash Flow > depreciation
782
Annuals > 2 > cash Flow > change In Working Capital
34716
Annuals > 2 > cash Flow > cash From Operations
-117945
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
90347
Annuals > 2 > cash Flow > cash From Financing
-35078
Annuals > 2 > cash Flow > net Change In Cash
-63337
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.1357282599449943
Annuals > 2 > ratios > PB
77.46888270610631
Annuals > 2 > ratios > ROE
-269.91262751989063
Annuals > 2 > ratios > ROA
-194.61866047231902
Annuals > 2 > ratios > FCF
-117945
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
36193000
Annuals > 3 > income Statement > cost Of Revenue
18111000
Annuals > 3 > income Statement > gross Profit
18082000
Annuals > 3 > income Statement > operating Expenses
669496000
Annuals > 3 > income Statement > operating Income
-83472000
Annuals > 3 > income Statement > interest Expense
9458000
Annuals > 3 > income Statement > pretax Income
-83436000
Annuals > 3 > income Statement > net Income
-626539000
Annuals > 3 > income Statement > eps
-17.940069865994733
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
34924000
Annuals > 3 > income Statement > income Tax Expense
-4941000
Annuals > 3 > income Statement > EBITDA
-603911000
Annuals > 3 > income Statement > operating Margin
-230.63023236537452
Annuals > 3 > income Statement > total Other Income Expense Net
36000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
102255000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
43817000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
158944000
Annuals > 3 > balance Sheet > property Plant Equipment
8419000
Annuals > 3 > balance Sheet > total Assets
173229000
Annuals > 3 > balance Sheet > payables
41781000
Annuals > 3 > balance Sheet > short Term Debt
33561000
Annuals > 3 > balance Sheet > long Term Debt
2482000
Annuals > 3 > balance Sheet > total Liabilities
163890000
Annuals > 3 > balance Sheet > equity
9339000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-626539000
Annuals > 3 > cash Flow > depreciation
18111000
Annuals > 3 > cash Flow > change In Working Capital
-932000
Annuals > 3 > cash Flow > cash From Operations
-602571000
Annuals > 3 > cash Flow > capital Expenditures
994000
Annuals > 3 > cash Flow > cash From Investing
46000
Annuals > 3 > cash Flow > cash From Financing
-30344000
Annuals > 3 > cash Flow > net Change In Cash
-624674000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-17.940069865994733
Annuals > 3 > ratios > PB
336.56280115644074
Annuals > 3 > ratios > ROE
-6708.844630046044
Annuals > 3 > ratios > ROA
-361.6825127432474
Annuals > 3 > ratios > FCF
-603565000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-16.676290995496366
Annuals > 3 > health Score
8
Valuation > metrics > PE
-28.001887237556026
Valuation > metrics > PB
0.00021123415093294944
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-0.006572172083494822
Profitability > metrics > ROA
-0.0077698501014597104
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.0436852887437019
Risk > metrics > Interest Coverage
-6.818627450980392
Risk > final Score
33
Risk > verdict
High
Liquidity > metrics > Current Ratio
19.362484157160964
Liquidity > metrics > Quick Ratio
19.362484157160964
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
42
Prev Risks > 0
30
Prev Risks > 1
60
Prev Risks > 2
63
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-22T21:14:58.859Z
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Orphazyme A/S
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.